drugset / Trial / NCT01259765

Llama Antibody, Rotavirus Diarrhoea, Children

NCT01259765 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

The investigators hypothesize that : oral administration of VHH batch 203027 will be * safe and tolerable for healthy Bangladeshi humans of all age groups (Part I) * effective in reducing severity of diarrhoea in children with proven rotavirus infection (Part II). This entry only covers Part II.

Timeline

Start
2006-01
Primary completion
2008-09
Completion
2009-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator VHH batch 203027 Protein / enzyme biologic 165 mg Oral

Indications